NCT06958510

Brief Summary

Orbito-Zygomaticomaxillary-complex fractures is a form of a complex orbital floor fracture, with affection of the inferior orbital rim and the orbital walls. According to published research, between 67 - 84 % of periorbital bone fractures are orbital floor fractures. Evaluation of 3D-Modified Anatomic Mesh in the management of OZM- complex fractures with orbital floor defect, and compare it with the conventional fixation configuration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 6, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

December 31, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

April 16, 2025

Last Update Submit

December 25, 2025

Conditions

Keywords

anatomical mesh3D-meshorbital meshorbital fracturezygomatic fracturereconstruction

Outcome Measures

Primary Outcomes (1)

  • Radiographic assessment of the management of the Orbito-Zygomaticomaxillary Complex fracture

    Radiographic assessment of the management of the Orbito-Zygomaticomaxillary Complex fracture

    1 week

Secondary Outcomes (1)

  • Periorbital ecchymosis

    6 weeks

Study Arms (2)

Patients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh

ACTIVE COMPARATOR

Patients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh

Device: 3D-Modified Anatomical-Mesh.

Patients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini

EXPERIMENTAL

Patients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini

Device: conventional orbital rim miniplates and orbital mesh configuration

Interventions

3D-Modified Anatomical-Mesh.

Patients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh

conventional orbital rim miniplates and orbital mesh configuration

Patients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering from Orbito-Zygomaticomaxillary complex fractures with fracture in the orbital floor and orbital floor defect(16).
  • Fractures that are indicated for open reduction and internal fixation.
  • Patients suffering from ocular complications:
  • Monocular diplopia.
  • Enophthalmos above 2 mm.
  • Restricted ocular motility.
  • Patients with orbital wall defects with orbital soft tissue herniation into the maxillary sinus.
  • Adult patient either male or female that agrees to present for follow-up visits for an adequate postoperative period.

You may not qualify if:

  • Patients with isolated orbital floor defects and blowout fractures.
  • Patients with isolated zygomatico-maxillary complex fracture with no orbital floor/ walls defects.
  • Patients with bilateral orbital defects.
  • Patients with Infected wounds in periorbital region.
  • Medically compromised patients rendering them inoperable.
  • Patients with ruptured globe or blindness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Alexandria Governorate, 21523, Egypt

Location

MeSH Terms

Conditions

Orbital FracturesZygomatic Fractures

Condition Hierarchy (Ancestors)

Maxillofacial InjuriesFacial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesSkull FracturesFractures, BoneWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Sequentially numbered, opaque, sealed envelopes (SNOSE) allocation concealment method will be utilized. Each participant included in the study will be given a serial number that will be used in the allocation. These numbers will be written in identical sheets of paper with the group to which each participant is allocated and placed inside opaque envelopes carrying the respective names of participants. A trial independent personnel will be assigned the role of keeping the envelopes and unfolding them only at the time of the operation, so that the participant is allocated to a group which is concealed from the operator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients with Orbito-Zygomaticomaxillary complex fractures with orbital floor defect managed with 3D-Modified Anatomic Mesh
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2025

First Posted

May 6, 2025

Study Start

October 1, 2024

Primary Completion

March 1, 2025

Study Completion

June 15, 2025

Last Updated

December 31, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study

Shared Documents
SAP
Access Criteria
to any one who required them after deidentification

Locations